Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC. | Heliyon | 2022 | 36311369 | PubTator, text mining | PubMed |
| LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. | Eur J Med Res | 2022 | 36307879 | PubTator, text mining | PubMed |
| Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. | Front Oncol | 2022 | 36300088 | PubTator, text mining | PubMed |
| Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. | Pathogens | 2022 | 36297203 | PubTator, text mining | PubMed |
| Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer. | Int J Mol Sci | 2022 | 36293321 | PubTator, text mining | PubMed |
| Construction of a Prognostic and Early Diagnosis Model for LUAD Based on Necroptosis Gene Signature and Exploration of Immunotherapy Potential. | Cancers (Basel) | 2022 | 36291937 | PubTator, text mining | PubMed |
| Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype. | Biomedicines | 2022 | 36289872 | PubTator, text mining | PubMed |
| Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma. | Front Genet | 2022 | 36276937 | PubTator, text mining | PubMed |
| Costimulators expressed on human endothelial cells modulate antigen-dependent recruitment of circulating T lymphocytes. | Front Immunol | 2022 | 36275645 | PubTator, text mining | PubMed |
| Ectopic expression of HIV-1 Tat modifies gene expression in cultured B cells: implications for the development of B-cell lymphomas in HIV-1-infected patients. | PeerJ | 2022 | 36275462 | PubTator, text mining | PubMed |
| A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer. | J Oncol | 2022 | 36268283 | PubTator, text mining | PubMed |
| The prognostic impact of the immune signature in head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36268020 | PubTator, text mining | PubMed |
| Transcriptome-wide m6A methylome analysis uncovered the changes of m6A modification in oral pre-malignant cells compared with normal oral epithelial cells. | Front Oncol | 2022 | 36249071 | PubTator, text mining | PubMed |
| Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36248785 | PubTator, text mining | PubMed |
| Integration of three machine learning algorithms identifies characteristic RNA binding proteins linked with diagnosis, immunity and pyroptosis of IgA nephropathy. | Front Genet | 2022 | 36246620 | PubTator, text mining | PubMed |
| Identification and characterization of blocking nanobodies against human CD70. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36239354 | PubTator, text mining | PubMed |
| CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2022 | 36238304 | PubTator, text mining | PubMed |
| Allergic Inflammation: Effect of Propolis and Its Flavonoids. | Molecules | 2022 | 36235230 | PubTator, text mining | PubMed |
| AI-Based Protein Interaction Screening and Identification (AISID). | Int J Mol Sci | 2022 | 36232986 | PubTator, text mining | PubMed |
| Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity. | Cells | 2022 | 36231109 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=37